Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Two IOP Lowering Medications in Caucasian and Japanese Subjects
NCT00047606Phase 4Terminated
- Sponsor
- Alcon Inc.
- Start
- Aug 2002
- Primary completion
- Nov 2003
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 4 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Aug 2002; status: terminated.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00047606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047606.